Tuhura Biosciences Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.34

+0.05 (+2.18%)

As of Jun 30, 10:43 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +494.4% upside

Low Target $12.64

Average Target $13.91

High Target $18.47

Current Price $2.34

Current
$2.34

Target
$13.91

$12.64 $13.91 avg $18.47

Scenario Analysis

Bear Case

$12.64

440.2%

Low target

Base Case

$13.91

+494.4%

Avg target

Bull Case

$18.47

+689.3%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$3.90

-40.0% from high

52-Week Low

$0.41

+470.7% from low

Target vs 52W High

$13.91

+256.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%